in parallel with an ongoing clinical trial in patients with metastatic mammary carcinoma , we compared the three-drug combination of cyclophosphamide , tegafur , and methotrexate with the two-drug combination of cyclophosphamide and tegafur in the murine l1210 leukemia and b16 melanoma models .
C0010583
cyclophosphamide
C0281491
methotrexate